Prospective adjuvant therapy with mitomycin C and Carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU study group, the first study for colorectal cancer

Journal of Surgical Oncology

Volumn 62, Issue 1, 1996, Pages 4-9

  Ito, Katsuki ^a   Yamaguchi, Akihiro ^b   Miura, Kaoru ^c   Kato, Tomoyuki ^d   Koike, Akihiko ^e   Takagi, Hiroshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

adjuvant chemotherapy; Carmofur; colorectal cancer; MMC

Indexed keywords

ANTINEOPLASTIC AGENT; CARMOFUR; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; POLLAKISURIA; POSTOPERATIVE CARE; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0029863760     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199605)62:1<4::AID-JSO2>3.0.CO;2-D     Document Type: Article

References (14)

1. Hoshi A, Igo M, Kuretani K, et al.: Anti tumor activity of 1 hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors. Gann 67:725-731, 1976.
2. Koyama Y: 1-Hexylcarbamoyl-5-fluorinated Pyrimidine. Cancer Treatment Reviews 8:147-156, 1981.
3. Ichihashi H, Takagi H, Kondo T, et al.: Prospective adjuvant chemotherapy of Mitomycin C plus HCFU for colorectal cancer, 2nd report: 6 year survival after surgery. Jap J Cancer Clin 34:451-456, 1988.
4. Higgins GA, Dwight RW, Keehn RJ: Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Ann Surg 173:26-39, 1971.
5. Taylor I, et al.: A randomized controlled trial of adjuvant port 1 vein cytotoxic perfusion in colorectal cancer. Br J Surg 72:359-363, 1985.
6. Metzger U, et al.: Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality. World J Surg II: 452-458, 1987.
7. Moertel CG, et al.: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322:352-358, 1990.
8. Kato S: Adjuvant chemotherapy in carcinoma of the colon and rectum. Gan to Kagakuryouho 7:2067-2073, 1980.
9. Okuyama K, Isono K, et al.: Evaluation on the effectiveness of hepatic resection for colorectal cancer patients with liver metastases. J Jpn Soc Colo-proctol 46:116-122, 1993.
10. Morioka K, Muto T, et al.: Outcome of adjuvant mifurolo chemotherapy in patients given a resection of a colonic carcinoma. Jap J Cancer Clin 35:1031-1041, 1989.
11. Niimoto M, Hattori T, Inokuchi E, et al.: Mitomycin C plus Carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (Interim Report) Jpn J Surg 17:354-361, 1987.
12. Ito K, Watanabe T, Takagi H, et al.: Prospective adjuvant therapy of mitomycin C plus Carmofur (HCFU) for colorectal cancer. J Jap Soc Cancer Ther 24:2201, 1989.
13. Mastumoto S, Yoshizaki S, et al.: Comparison of the concentration of HCFU, Tegafur and 5-FU in the thoracic duct lymph after oral administration of HCFU and Tegafur. Gan to Kagakuryoho 12:1697-1698, 1985
14. Kato T, Nakazato H, Takagi H, et al.: A prospective radomized controlled trial of adjuvant Carmofur (HCFU) in colorectal cancer (third report). Jap Soc Cancer Ther 28:1306, 1993.